Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c507 |
|---|---|
| Identifier | NCT05158517 |
| Trial Title | VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Subcutaneous vedolizumab |
Participant Information
| Sponsor | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives |
|---|---|
| City | Grenoble |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-03-20 |
|---|---|
| Primary Completion Date | 2024-03-31 |
| Completion Date | 2025-03-20 |